| Literature DB >> 25147720 |
Bita Bakhshi1, Nazanin Eftekhari2, Mohammad Reza Pourshafie3.
Abstract
BACKGROUND: Integrons are the major reasons of multidrug resistance (MDR) among enteropathogenic bacteria. Occurrence of horizontal gene transfer between integron-carrying microorganisms and other enteric bacteria may increase the rate of emergence of integron-associated antibiotic resistance.Entities:
Keywords: Antimicrobial Agents; Drug Resistance; Integrons; Intestinal Bacteria
Year: 2014 PMID: 25147720 PMCID: PMC4138638 DOI: 10.5812/jjm.9924
Source DB: PubMed Journal: Jundishapur J Microbiol ISSN: 2008-3645 Impact factor: 0.747
Primers Used in This Study
| Target | Primer Sequences 5'-3' | Amplicon Size, bp | Reference |
|---|---|---|---|
|
| 422 | ( | |
| ACACTCCGATTCCTCTGGTG | |||
| CTTGCACATAAGCAGGCAAA | |||
|
| 243 | ( | |
| ACAGTGCTCGTTTACGACCTGAAT | |||
| AGACGACTGGTACTGATCGATAAT | |||
|
| 620 | ( | |
| GTTCCTTGACCGCCTTTCCGTTACCGTC | |||
| GCCGGTCAGCCACCCTCTGAGAGTAC | |||
|
| 300 | ( | |
| AGTCACTTAACCATTCAACCCG | |||
| TTAAGCGTTTTCGCTGAGAATG | |||
|
| 900 | ( | |
| TGCGTGTAAATCATCGTCGT | |||
| CAAGGTTCTGGACAGTTGC |
Antimicrobial Susceptibility Testing of the Isolates [a], [b]
| Bacteria | SXT | TE | TMP | STR | CIP | CHL | AMP |
|---|---|---|---|---|---|---|---|
|
| 28 (100) | 28 (100) | 28 (100) | 28 (100) | 28 (100) | 28 (100) | 28 (100) |
|
| 10 (27.8) | 17 (47.2) | 10 (27.8) | 17 (47.2) | 4 (11.1) | 1 (2.8) | 9 (25) |
|
| 30 (93.7) | 28 (84.3) | 30 (93.7) | 13 (40.6) | 1 (3.1) | 7 (18.7) | 12 (37.5) |
|
| 23 (95.8) | 0 (0) | 23 (95.8) | 23 (95.8) | 2 (8.3) | 22 (91.7) | 3 (12.5) |
|
| 91 (75.8) | 73 (60.8) | 91 (75.8) | 81 (67.5) | 35 (29.2) | 58 (48.3) | 52 (43.3) |
a Abbreviations: AMP, aminoglycosides; CHL, amphenicols; CIP, fluoroquinolones; STR, ; SXT, sulfonamides; TE, tetracyclines; TMP, trimethoprim alone.
b Data are presented in No. (%).
Figure 1.PCR Amplifications Performed in This Study.
A) PCR amplification of integrase gene (int) of class 1 integron; lanes 1-4: int+ isolates, lane 5: positive control, lane 6: negative control. B) PCR amplification of eae gene; lanes 1-4: eae+ isolates, lane 5: positive control. C) PCR amplification of ipaH gene; lanes 1-3: ipaH+ isolates, lane 4: positive control, lane 5: negative control. D) PCR amplification of hilA gene; lanes 3-6: hilA+ isolates, lane 2: positive control, lane 1: negative control. E) PCR amplification of 16s-23s intergenic spacer region of V. cholerae; lanes 2-6: positive isolates, lane 1: positive control, lane 7: negative control.